132 related articles for article (PubMed ID: 37838154)
1. Molecular diagnosis in patients with monogenic diabetes mellitus, and detection of a novel candidate gene.
Goksen D; Evin F; Isik E; Ozen S; Atik T; Ozkinay F; Akcan N; Ozkan B; Buyukinan M; Nuri Ozbek M; Darcan S; Onay H
Diabetes Res Clin Pract; 2023 Nov; 205():110953. PubMed ID: 37838154
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach.
Alkorta-Aranburu G; Carmody D; Cheng YW; Nelakuditi V; Ma L; Dickens JT; Das S; Greeley SAW; Del Gaudio D
Mol Genet Metab; 2014 Dec; 113(4):315-320. PubMed ID: 25306193
[TBL] [Abstract][Full Text] [Related]
3. [Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies].
Liu XZ; Li YY; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):836-844. PubMed ID: 33047716
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
[TBL] [Abstract][Full Text] [Related]
6. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
[TBL] [Abstract][Full Text] [Related]
7. The Application of Next Generation Sequencing Maturity Onset Diabetes of the Young Gene Panel in Turkish Patients from Trakya Region.
Yalçıntepe S; Özgüç Çömlek F; Gürkan H; Demir S; Atlı Eİ; Atlı E; Eker D; Tütüncüler Kökenli F
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):320-331. PubMed ID: 33565752
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of multigene screening with phenotype-driven bioinformatics analysis for the diagnosis of patients with monogenic diabetes or severe insulin resistance.
Hosoe J; Miya F; Kadowaki H; Fujiwara T; Suzuki K; Kato T; Waki H; Sasako T; Aizu K; Yamamura N; Sasaki F; Kurano M; Hara K; Tanaka M; Ishiura H; Tsuji S; Honda K; Yoshimura J; Morishita S; Matsuzawa F; Aikawa SI; Boroevich KA; Nangaku M; Okada Y; Tsunoda T; Shojima N; Yamauchi T; Kadowaki T
Diabetes Res Clin Pract; 2020 Nov; 169():108461. PubMed ID: 32971154
[TBL] [Abstract][Full Text] [Related]
9. Delineation of the genetic and clinical spectrum, including candidate genes, of monogenic diabetes: a multicenter study in South Korea.
Cheon CK; Lee YJ; Yoo S; Lee JH; Lee JE; Kim HJ; Choi IJ; Choi Y; Lee S; Yoon JY
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1539-1550. PubMed ID: 33031055
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome.
Bonnefond A; Durand E; Sand O; De Graeve F; Gallina S; Busiah K; Lobbens S; Simon A; Bellanné-Chantelot C; Létourneau L; Scharfmann R; Delplanque J; Sladek R; Polak M; Vaxillaire M; Froguel P
PLoS One; 2010 Oct; 5(10):e13630. PubMed ID: 21049026
[TBL] [Abstract][Full Text] [Related]
12. Study of ten causal genes in Turkish patients with clinically suspected maturity-onset diabetes of the young (MODY) using a targeted next-generation sequencing panel.
Doğan M; Eröz R; Bolu S; Yüce H; Gezdirici A; Arslanoğlu İ; Teralı K
Mol Biol Rep; 2022 Aug; 49(8):7483-7495. PubMed ID: 35733065
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis.
Donath X; Saint-Martin C; Dubois-Laforgue D; Rajasingham R; Mifsud F; Ciangura C; Timsit J; Bellanné-Chantelot C;
BMC Med; 2019 Jul; 17(1):132. PubMed ID: 31291970
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study to evaluate the strategy of combining clinical criteria and next generation sequencing (NGS) for the identification of monogenic diabetes among multi-ethnic Asians.
Ang SF; Lim SC; Tan CSh; Fong JC; Kon WY; Lian JX; Subramanium T; Sum CF
Diabetes Res Clin Pract; 2016 Sep; 119():13-22. PubMed ID: 27420379
[TBL] [Abstract][Full Text] [Related]
16. Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus?
Ali Khan I
Heliyon; 2021 Sep; 7(9):e07903. PubMed ID: 34584998
[TBL] [Abstract][Full Text] [Related]
17. Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes.
Zmysłowska A; Jakiel P; Gadzalska K; Majos A; Płoszaj T; Ben-Skowronek I; Deja G; Glowinska-Olszewska B; Jarosz-Chobot P; Klonowska B; Kowalska I; Mlynarski W; Mysliwiec M; Nazim J; Noczynska A; Robak-Kontna K; Skala-Zamorowska E; Skowronska B; Szadkowska A; Szypowska A; Walczak M; Borowiec M
Diabetes Res Clin Pract; 2022 Jan; 183():109154. PubMed ID: 34826540
[TBL] [Abstract][Full Text] [Related]
18. Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure.
Saglia C; Bracciamà V; Trotta L; Mioli F; Faini AC; Brach Del Prever GM; Kalantari S; Luca M; Romeo CM; Scolari C; Peruzzi L; Calvo PL; Mussa A; Fenoglio R; Roccatello D; Alberti C; Carli D; Amoroso A; Deaglio S; Vaisitti T
BMC Med Genomics; 2023 Nov; 16(1):303. PubMed ID: 38012624
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
20. Clinical whole exome sequencing in early onset diabetes patients.
Kwak SH; Jung CH; Ahn CH; Park J; Chae J; Jung HS; Cho YM; Lee DH; Kim JI; Park KS
Diabetes Res Clin Pract; 2016 Dec; 122():71-77. PubMed ID: 27810688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
